Anika Therapeutics, Inc. (ANIK)

Anika Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 15, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	128	241	332	432	517	643
Market Cap Growth	-59.68%	-27.34%	-23.28%	-16.40%	-19.60%	-13.05%
Enterprise Value	98	206	290	376	447	567
Last Close Price	8.64	16.46	22.66	29.60	35.83	45.26
PE Ratio	-	-	-	-	125.13	-
Forward PE	222.50	39.19	-	-	-	62.00
PS Ratio	1.09	2.01	2.75	3.80	3.50	4.93
PB Ratio	0.84	1.57	1.56	1.51	1.80	2.36
P/TBV Ratio	0.92	1.67	1.64	2.12	2.63	3.72
P/FCF Ratio	-	-	-	-	158.96	56.25
P/OCF Ratio	20.14	44.62	-	98.08	61.60	49.24
PEG Ratio	10.80	4.60	-	-	161.40	3.10
EV/Sales Ratio	0.86	1.72	2.40	3.30	3.03	4.34
EV/EBITDA Ratio	-	56.88	18.37	20.70	194.39	151.74
EV/EBIT Ratio	-	-	182.42	102.39	-	-
EV/FCF Ratio	-	-	-	-	137.51	49.55
Debt / Equity Ratio	0.17	0.17	0.13	0.11	0.07	0.08
Debt / EBITDA Ratio	11.17	3.48	1.42	1.44	4.12	3.52
Debt / FCF Ratio	-	-	-	-	6.44	1.96
Asset Turnover	0.51	0.51	0.39	0.33	0.41	0.38
Inventory Turnover	1.41	1.80	1.17	1.07	1.42	1.80
Quick Ratio	4.80	3.40	3.06	4.33	4.17	3.32
Current Ratio	6.18	4.88	5.26	6.07	5.66	4.81
Return on Equity (ROE)	-7.23%	-4.82%	-1.38%	0.77%	1.48%	-8.55%
Return on Assets (ROA)	-2.40%	-1.19%	0.32%	0.66%	-2.11%	-1.75%
Return on Capital (ROIC)	-2.63%	-1.34%	0.36%	0.73%	-2.49%	-2.01%
Return on Capital Employed (ROCE)	-	-	0.70%	1.10%	-	-
Earnings Yield	-47.95%	-23.39%	-24.92%	-3.44%	0.80%	-3.73%
FCF Yield	-0.42%	-0.97%	-2.17%	-0.71%	0.63%	1.78%
Buyback Yield / Dilution	1.38%	-0.44%	-0.65%	0.50%	-2.90%	1.06%

Updated Jul 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q